Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 4 Prophylaxis ordered in intervention and control groups

From: Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial

  Patients in intervention group receiving Patients in control group receiving
No prophylaxis 62% 73%
Unfractionated heparin at suggested prophylaxis dose 23% 19%
Low-molecular-weight heparin at suggested prophylaxis dose 11% 14%
Anti-embolic stockings 6% 2%
Intermittent pneumatic compression devices 0% 0%